Russell H Neubauer

Title: The Innovations of Russell H Neubauer

Introduction

Russell H Neubauer is a notable inventor based in West Chester, PA, with a significant contribution to the field of pharmaceuticals. He holds three patents that focus on innovative compounds and formulations aimed at treating various medical conditions. His work has implications for immunosuppressive therapies and the treatment of autoimmune diseases.

Latest Patents

One of Neubauer's latest patents involves 4-quinoline carboxylic acid derivatives, which are useful as immunosuppressive agents. These compounds, including 2-(2'-fluoro-1,1'-biphenyl-4-yl)-6-fluoro-3-methyl-4-quinolinecarboxylic acid, have shown potential as immunomodulatory and anti-inflammatory agents. They are particularly relevant for treating autoimmune diseases, organ transplantation rejection, graft vs. host disease, multiple sclerosis, and chronic inflammatory diseases such as rheumatoid arthritis. Another significant patent relates to stable mammalian cell lines that express a desired protein linked to a regulatory control sequence, enhancing the efficiency of protein production.

Career Highlights

Throughout his career, Neubauer has worked with prominent companies in the pharmaceutical industry, including DuPont Merck Pharmaceutical and E.I. du Pont de Nemours and Company. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Neubauer has collaborated with notable colleagues such as Neil R Ackerman and Scott E Loveless, further enriching his work and contributions to the field.

Conclusion

Russell H Neubauer's innovative patents and career in the pharmaceutical industry highlight his significant contributions to medical science. His work continues to impact the development of treatments for various diseases, showcasing the importance of innovation in healthcare.